AEZS
Price
$2.18
Change
+$0.10 (+4.81%)
Updated
Mar 28, 1:51 PM EST
40 days until earnings call
CMRX
Price
$1.08
Change
+$0.08 (+7.92%)
Updated
Mar 28, 2:00 PM EST
42 days until earnings call
Ad is loading...

AEZS vs CMRX ᐉ Comparison: Which is Better to Invest?

Header iconAEZS vs CMRX Comparison
Open Charts AEZS vs CMRXBanner chart's image
Aeterna Zentaris
Price$2.18
Change+$0.10 (+4.81%)
Volume$227
CapitalizationN/A
Chimerix
Price$1.08
Change+$0.08 (+7.92%)
Volume$1.5K
CapitalizationN/A
View a ticker or compare two or three
AEZS vs CMRX Comparison Chart

Loading...

AEZSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
CMRXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
AEZS vs. CMRX commentary
Mar 28, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEZS is a StrongBuy and CMRX is a Hold.

COMPARISON
Comparison
Mar 28, 2024
Stock price -- (AEZS: $2.10 vs. CMRX: $1.01)
Brand notoriety: AEZS and CMRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AEZS: 138% vs. CMRX: 62%
Market capitalization -- AEZS: $10.11M vs. CMRX: $90.1M
AEZS [@Biotechnology] is valued at $10.11M. CMRX’s [@Biotechnology] market capitalization is $90.1M. The market cap for tickers in the [@Biotechnology] industry ranges from $576.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.64B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AEZS’s FA Score shows that 0 FA rating(s) are green whileCMRX’s FA Score has 0 green FA rating(s).

  • AEZS’s FA Score: 0 green, 5 red.
  • CMRX’s FA Score: 0 green, 5 red.
According to our system of comparison, AEZS is a better buy in the long-term than CMRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AEZS’s TA Score shows that 7 TA indicator(s) are bullish while CMRX’s TA Score has 6 bullish TA indicator(s).

  • AEZS’s TA Score: 7 bullish, 3 bearish.
  • CMRX’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, AEZS is a better buy in the short-term than CMRX.

Price Growth

AEZS (@Biotechnology) experienced а +1.45% price change this week, while CMRX (@Biotechnology) price change was +2.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.09%. For the same industry, the average monthly price growth was +5.19%, and the average quarterly price growth was +89.27%.

Reported Earning Dates

AEZS is expected to report earnings on May 07, 2024.

CMRX is expected to report earnings on May 09, 2024.

Industries' Descriptions

@Biotechnology (+5.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for AEZS with price predictions.
OPEN
A.I.dvisor published
a Summary for CMRX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CMRX($90.1M) has a higher market cap than AEZS($10.1M). AEZS YTD gains are higher at: 12.903 vs. CMRX (4.935). AEZS has higher annual earnings (EBITDA): -22.93M vs. CMRX (-92.97M). CMRX has more cash in the bank: 183M vs. AEZS (38.8M). AEZS has less debt than CMRX: AEZS (217K) vs CMRX (1.3M). AEZS has higher revenues than CMRX: AEZS (6.86M) vs CMRX (324K).
AEZSCMRXAEZS / CMRX
Capitalization10.1M90.1M11%
EBITDA-22.93M-92.97M25%
Gain YTD12.9034.935261%
P/E RatioN/A0.47-
Revenue6.86M324K2,118%
Total Cash38.8M183M21%
Total Debt217K1.3M17%
FUNDAMENTALS RATINGS
AEZS vs CMRX: Fundamental Ratings
AEZS
CMRX
OUTLOOK RATING
1..100
1368
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
63
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9797
PRICE GROWTH RATING
1..100
5861
P/E GROWTH RATING
1..100
9394
SEASONALITY SCORE
1..100
5041

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AEZS's Valuation (49) in the Biotechnology industry is in the same range as CMRX (63). This means that AEZS’s stock grew similarly to CMRX’s over the last 12 months.

AEZS's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CMRX (100). This means that AEZS’s stock grew similarly to CMRX’s over the last 12 months.

AEZS's SMR Rating (97) in the Biotechnology industry is in the same range as CMRX (97). This means that AEZS’s stock grew similarly to CMRX’s over the last 12 months.

AEZS's Price Growth Rating (58) in the Biotechnology industry is in the same range as CMRX (61). This means that AEZS’s stock grew similarly to CMRX’s over the last 12 months.

AEZS's P/E Growth Rating (93) in the Biotechnology industry is in the same range as CMRX (94). This means that AEZS’s stock grew similarly to CMRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AEZSCMRX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
68%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
76%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 10 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Ad is loading...
AEZSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
CMRXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NWBO0.600.07
+12.99%
Northwest Biotherapeutics
BSXGF0.04N/A
+5.42%
Belo Sun Mining Corp
TRUMY37.350.45
+1.23%
Terumo Corp
MBGAF79.720.27
+0.34%
Mercedes Benz Group AG
CHYHY19.58N/A
N/A
CHR Hansen Hldg A/S

CMRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CMRX has been loosely correlated with CRSP. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CMRX jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMRX
1D Price
Change %
CMRX100%
+2.02%
CRSP - CMRX
43%
Loosely correlated
-1.14%
AVIR - CMRX
38%
Loosely correlated
+6.10%
ALNY - CMRX
38%
Loosely correlated
+1.55%
FGEN - CMRX
35%
Loosely correlated
+5.53%
MRSN - CMRX
34%
Loosely correlated
+4.65%
More